PAR-22-032 - Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 1
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): AI/ML in Pre-Clinical Drug Development for Psychiatric Disorders | NOT-MH-25-050 | NIMH | Dec 20, 2024 | Jan 8, 2029 | R21, R01 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|